# CERO: Where and When to Allocate Rollouts for RL Post-Training

Preprint · Yiming Zong, Yige Wang, Xing Hu, Jiashuo Jiang, Zuo-Jun Max Shen

- Archive id: arxiv:2610.09679
- Published: 2026-10-07
- arXiv: https://arxiv.org/abs/2610.09679
- Source URL: https://arxiv.org/abs/2610.09679
- PDF: https://arxiv.org/pdf/2610.09679
- Provenance: arxiv

## Abstract

Adaptive rollout methods for group-relative reinforcement learning typically allocate a fixed per-update budget across prompts. We instead study how to coordinate a finite rollout budget over the entire training horizon. We formulate this problem using a concave surrogate utility of cumulative prompt exposure and introduce CERO, an online primal dual scheduler for prompt admission and budget pacing. In our experiments, each admitted prompt receives a fixed-size response group. CERO instead adapts which prompts are selected, how often they are revisited across rounds, and how many groups are generated in each round. A compact Fenchel representation linearizes the dependence on cumulative exposure, while projected online gradient descent updates prompt-specific supporting slopes and a shared budget price using reward-variation feedback and budget deviations. We establish pathwise guarantees for the surrogate allocation objective against fixed-rate and same-path time-varying benchmarks, with explicit terms for proxy discrepancy and rate variation. Under matched training-response budgets, CERO attains the highest avg@16 macro-average on each of three backbones across five mathematical reasoning benchmarks. Mechanistic analyses link CERO's prompt choices to within-group reward contrast, while multi-seed ablations show gains from adaptive pacing over both uniform and preset spending schedules.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.